Conflicts of Interest at the NIH: No Easy Solution [Book Review]

Hastings Center Report 35 (1):18-20 (2012)
  Copy   BIBTEX

Abstract

Editor's Note: On February 2, 2005, the National Institutes of Health changed course on conflicts of interest and prohibited its scientists from owning stock in or working as consultants with pharmaceutical or biotechnology companies. The following essay, sent to press before the new policy was announced, recommends a very different approach. The author stands by the recommendations.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,100

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Conflicts of interest at the NIH: No easy solution.David M. Resnick - 2005 - Hastings Center Report 35 (1):18-20.
Conflicts of interest in science.David B. Resnik - 1998 - Perspectives on Science 6 (4):381-408.
The Dirt on Coming Clean.Daylian M. Cain, George Loewenstein & Don A. Moore - 2007 - International Corporate Responsibility Series 3:81-99.
The troublesome semantics of conflict of interest.Paul J. Friedman - 1992 - Ethics and Behavior 2 (4):245 – 251.
The Dirt on Coming Clean.Daylian M. Cain, George Loewenstein & Don A. Moore - 2007 - International Corporate Responsibility Series 3:81-99.
Conflicts of interest.Thomas L. Carson - 1994 - Journal of Business Ethics 13 (5):387 - 404.
Conflicts of interest in medicine: a philosophical and ethical morphology.Edmund L. Erde - 1996 - In Roy G. Spece, David S. Shimm & Allen E. Buchanan (eds.), Conflicts of Interest in Clinical Practice and Research. Oxford University Press. pp. 12--41.

Analytics

Added to PP
2014-03-20

Downloads
18 (#834,465)

6 months
1 (#1,474,534)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

References found in this work

No references found.

Add more references